Integration of Palliative Pharmacists to Elevate Oncologic Care
Palliative pharmacists are invaluable assets of oncologic care.
Related Articles
PurpleStride Delaware 2025 – Pancreatic Cancer Action Network
PurpleStride is a year-round national movement that funds life-changing programs and services for pancreatic cancer patients. Your participation and fundraising make it all possible.
FDA Approves Larotrectinib for Adult and Pediatric Patients With NTRK Gene Fusion-Positive Solid Tumors
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments,…
From Inpatient to Outpatient: A Pharmacy-Led Evolution in Transplant Care
Erin Lexner, PharmD, BCPS, discussed her team’s experience transitioning to outpatient BEAM from inpatient CBV.
FDA Approves Dupilumab, Marking First Targeted Therapy in a Decade for Chronic Spontaneous Urticaria
Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.
FDA Approves Nivolumab With Ipilimumab for First-Line Treatment of Adult Patients With HCC
Patients with unresectable or metastatic hepatocellular carcinoma (HCC) receiving this regimen had favorable median overall survival (23.7 months) compared with standard of care (20.6 months).
The Evolving Pharmacist Role in HER2-Negative Adjuvant Breast Cancer Therapy
Julia Ziegengeist, PharmD, BCOP offers insights for pharmacists navigating adjuvant and neoadjuvant treatment of breast cancer.
AZD0780, Novel Oral PCSK9 Inhibitor, Demonstrates Major LDL Cholesterol Reductions
When used in combination with background statin therapy, AZD0780 resulted in major reductions in low-density lipoprotein cholesterol (LDL-C) and achievements of guideline-recommended LDL-C goals.
Insights From HOPA 2025: Pharmacists Discuss CAR-T Safety at a Comprehensive Cancer Center
Amir Ali, PharmD, BCOP, and Allison Hsieh, PharmD share insights from their presentation about cytokine release syndrome, ICANS, and CAR T-cell therapy.
ONS Biomarker Database | Oncology Nursing Society
Curated for oncology nurses by oncology nurses to bring precision oncology and the most recent biomarker advances to the point of care. New cancer types…
Study Finds ADHD Stimulants Have Minimal Effect on Cardiovascular System
Small changes in blood pressure and pulse were shown in patients of all ages, and the authors suggested that these are monitored carefully in patients…